Fine mapping of a major histocompatibility complex in ankylosing spondylitis: Association of the HLA-DPA1 and HLA-DPB1 regions

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3305-3312

  Díaz Peña, Roberto ^a   Aransay, Ana M ^b   Bruges Armas, Jacome ^c   López Vázquez, Antonio ^a   Rodríguez Ezpeleta, Naiara ^b   Mendibil, Iñaki ^b   Sánchez, Alejandra ^d   Torre Alonso, Juan Carlos ^e   Bettencourt, Bruno F ^c   Mulero, Juan ^d   Collantes, Eduardo ^f   López Larrea, Carlos ^g  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b CIC BIOGUNE   (Spain)

^c UNIVERSITY OF PORTO   (Portugal)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e HOSPITAL MONTE NARANCO   (Spain)

^f UNIVERSITY OF CÓRDOBA   (Spain)

^g Section of Nephrology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; HLA DPB1 ANTIGEN;

ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-DP ALPHA-CHAINS; HLA-DP BETA-CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING;

EID: 80155206212     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30555     Document Type: Article

References (36)

1. Brown MA, Laval SH, Brophy S, Calin A,. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000; 59: 883-6.
2. Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 1823-8. (Pubitemid 27452533)
3. Thomas GP, Brown MA,. Genetics and genomics of ankylosing spondylitis. Immunol Rev 2010; 233: 162-80.
4. Taurog JD,. Animal models of spondyloarthritis. Adv Exp Med Biol 2009; 649: 245-54.
5. Khan MA,. Remarkable polymorphism of HLA-B27: an ongoing saga. Curr Rheumatol Rep 2010; 12: 337-41.
6. Wei JC, Tsai WC, Lin HS, Tsai CY, Chou CT,. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford) 2004; 43: 839-42. (Pubitemid 38996956)
7. Yamaguchi A, Tsuchiya N, Mitsui H, Shiota M, Ogawa A, Tokunaga K, et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients: evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum 1995; 38: 1672-7.
8. Lopez-Larrea C, Mijiyawa M, Gonzalez S, Fernandez-Morera JL, Blanco-Gelaz MA, Martínez-Borra J, et al. Association of ankylosing spondylitis with HLA-B*1403 in a West African population. Arthritis Rheum 2002; 46: 2968-71. (Pubitemid 35315890)
9. Diaz-Pena R, Blanco-Gelaz MA, Njobvu P, Lopez-Vazquez A, Suarez-Alvarez B, Lopez-Larrea C,. Influence of HLA-B*5703 and HLA-B*1403 on the susceptibility to spondyloarthropathies in the Zambian population. J Rheumatol 2008; 35: 2236-40.
10. Robinson WP, van der Linden SM, Khan MA, Rentsch HU, Cats A, Russell A, et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 1989; 32: 1135-41. (Pubitemid 19237868)
11. Reveille JD,. Major histocompatibility genes and ankylosing spondylitis. Best Pract Res Clin Rheumatol 2006; 20: 601-9. (Pubitemid 43869449)
12. Van de Linden S, Valkenburg HA, Cats A,. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8. (Pubitemid 14134775)
13. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS,. BeadArray technology: enabling and accurate, cost-effective approach to high-throughput genotyping. Biotechniques 2002; Suppl: 56-8, 60-1.
14. Aldener-Cannava A, Olerup O,. HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations. Tissue Antigens 1996; 48: 153-6.
15. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75. (Pubitemid 47330214)
16. Haploview software. Broad Institute of MIT and Harvard. URL:.
17. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9. (Pubitemid 34680308)
18. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D,. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-9. (Pubitemid 44141658)
19. Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JL,. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998; 41: 460-5. (Pubitemid 28128771)
20. Said-Nahal R, Miceli-Richard C, Gautreau C, Tamouza R, Borot N, Porcher R, et al. The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families. Ann Rheum Dis 2002; 61: 201-6. (Pubitemid 34177748)
21. Sims AM, Barnardo M, Herzberg I, Bradbury L, Calin A, Wordsworth BP, et al. Non-B27 MHC associations of ankylosing spondylitis. Genes Immun 2007; 8: 115-23. (Pubitemid 46390909)
22. Paladini F, Belfiore F, Cocco E, Carcassi C, Cauli A, Vacca A, et al. HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia. Arthritis Res Ther 2009; 11: R171.
23. Hedrick PW, Thomson G,. Evidence for balancing selection at HLA. Genetics 1983; 104: 449-56. (Pubitemid 13011682)
24. Klitz W, Thomson G, Baur MP,. Contrasting evolutionary histories among HLA loci. Am J Hum Genet 1986; 39: 340-9. (Pubitemid 17170836)
25. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL,. Polymorphism, recombination and linkage disequilibrium within the HLA class II region. J Immunol 1992; 148: 249-58.
26. Begovich AB, Moonsamy PV, Mack SJ, Barcellos LF, Steiner LL, Grams S, et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens 2001; 57: 424-39. (Pubitemid 32588548)
27. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591-5.
28. Richeldi L, Sorrentino R, Saltini C,. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993; 262: 242-4. (Pubitemid 23344468)
29. Begovich AB, Bugawan TL, Nepom BS, Klitz W, Nepom GT, Erlich HA,. A specific HLA-DPβ allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis. Proc Natl Acad Sci U S A 1989; 86: 9489-93. (Pubitemid 20010452)
30. Lympany PA, Petrek M, Southcott AM, Newman Taylor AJ, Welsh KI, du Bois RM,. HLA-DPB polymorphisms: Glu 69 association with sarcoidosis. Eur J Immunogenet 1996; 23: 353-9. (Pubitemid 26345392)
31. Cruz TD, Valdes AM, Santiago A, Frazer de Llado T, Raffel LJ, Zeidler A, et al. DPB1 alleles are associated with type 1 diabetes susceptibility in multiple ethnic groups. Diabetes 2004; 53: 2158-63. (Pubitemid 38970770)
32. Varney MD, Valdes AM, Carlson JA, Noble J, Tait BD, Bonella P, et al, for the Type 1 Diabetes Genetics Consortium. HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes 2010; 59: 2055-62.
33. Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK, et al. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum 2009; 60: 3807-14.
34. + T lymphocytes. J Immunol 2001; 167: 2619-24. (Pubitemid 32768890)
35. Visone R, Croce CM,. MiRNAs and cancer. Am J Pathol 2009; 174: 1131-8.
36. Alevizos I, Illei GG,. MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol 2010; 6: 391-8.